SEZ6L

Across TCGA pan-cancer cohorts, SEZ6L mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SEZ6L data layer compared with 22 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher SEZ6L mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SEZ6L expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

GBM are the cancer types where SEZ6L mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Quartile	All	0.499	0.273	.022	7	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

SEZ6L–GBM (DFS)

Open the GBM breakdown →